Contemporary Management of the High-Risk Pulmonary Embolism: The Clot Thickens.
Clinical Decision-Making
/ methods
Combined Modality Therapy
Critical Care
/ methods
Critical Illness
Embolectomy
/ methods
Extracorporeal Membrane Oxygenation
Fibrinolytic Agents
/ therapeutic use
Heart Arrest
/ etiology
Humans
Pulmonary Embolism
/ complications
Resuscitation
/ methods
Risk
Risk Assessment
Thrombolytic Therapy
/ methods
antithrombotic drugs
critical care
critical illness
intensive care unit
resuscitation
Journal
Journal of intensive care medicine
ISSN: 1525-1489
Titre abrégé: J Intensive Care Med
Pays: United States
ID NLM: 8610344
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
pubmed:
3
8
2018
medline:
9
1
2020
entrez:
3
8
2018
Statut:
ppublish
Résumé
Pulmonary embolism (PE) is a common disease process encountered in the acute care setting. It presents on a spectrum of severity with the most severe presentations carrying a substantial risk of morbidity and mortality. In recent years, a wide range of competing treatment strategies have been proposed for the high-risk PE including new catheter-based and extracorporeal techniques, and management has become more challenging. There is currently no consensus as to the optimal approach to treatment. Contemporary management decisions are informed by the balance between the risk of deterioration and the risk of harm from intervention, within the available resources. This review will summarize the current evidence to better inform clinical decision-making in high-risk PE and highlight future directions in management.
Identifiants
pubmed: 30068253
doi: 10.1177/0885066618789879
doi:
Substances chimiques
Fibrinolytic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM